Eyepoint Pharmaceuticals Inc (EYPT) Insider Trading

Total insider buys:
  • $120,813,690.84
Total insider sells:
  • $50,777,804.13
Most recent insider trade:
  • Aug. 20, 2024
Most active insider trader:
  • Paul Ashton
Trader NameDateTitleAmountPriceTypeTotal Value
Aug. 20, 2024Director2,567$7.79Buy$19,996.93
July 12, 2024Director11,625$10.06Sell$116,947.50
May 14, 2024Director11,625$12.65Sell$147,056.25
May 6, 2024Major Shareholder850,000$11.86Buy$10,081,000.00
April 18, 2024Major Shareholder581,765$18.03Buy$10,489,222.95
Feb. 2, 2024SVP209$28.49Sell$5,954.41
Jan. 26, 2024Insider49,325$25.66Sell$1,265,679.50
Jan. 25, 2024SVP600$25.00Sell$15,000.00
Jan. 23, 2024Insider5,135$25.00Sell$128,375.00
Jan. 23, 2024SVP900$25.00Sell$22,500.00
Jan. 11, 2024Major Shareholder750,000$19.75Buy$14,812,500.00
Jan. 11, 2024Director1,910,500$19.45Sell$37,159,225.00
Jan. 9, 2024Major Shareholder105,000$21.32Buy$2,238,600.00
Jan. 8, 2024Insider22,913$21.13Sell$484,151.69
Dec. 13, 2023Insider1,458$20.00Sell$29,160.00
Dec. 8, 2023Major Shareholder588,235$17.00Buy$9,999,995.00
Dec. 6, 2023Director266,242$18.41Sell$4,901,515.22
Dec. 4, 2023Major Shareholder1,919,057$21.82Buy$41,873,823.74
Dec. 4, 2023Insider45,000$22.00Sell$990,000.00
Sept. 1, 2023Major Shareholder20,000$9.90Sell$198,000.00
Aug. 30, 2023Major Shareholder60,976$10.92Sell$665,857.92
Aug. 28, 2023Major Shareholder60,858$11.71Sell$712,647.18
Aug. 24, 2023Major Shareholder139,280$14.62Sell$2,036,273.60
Aug. 22, 2023Major Shareholder46,778$14.62Sell$683,894.36
May 30, 2023Director1$6.00Sell$6.00
Sept. 4, 2020CFO10,000$0.48Buy$4,800.00
Aug. 24, 2020CFO10,000$0.61Buy$6,100.00
March 12, 2020CFO10,000$0.96Buy$9,600.00
March 10, 2020CEO98,000$1.06Buy$103,880.00
Nov. 15, 2019CFO10,000$1.43Buy$14,300.00
May 13, 2019Director40,000$1.74Buy$69,600.00
April 1, 2019Director5,000$1.89Buy$9,450.00
March 29, 2019Director17,000$1.75Buy$29,750.00
March 29, 2019CEO28,500$1.76Buy$50,160.00
June 25, 2018Major Shareholder16,864,066$1.27Buy$21,417,363.82
March 28, 2018Major Shareholder8,606,324$1.10Buy$9,466,956.40
June 14, 2017Insider56,700$1.76Buy$99,792.00
Jan. 4, 2016VP5,000$4.70Sell$23,500.00
Dec. 22, 2015VP33,950$5.39Sell$182,990.50
Dec. 22, 2015CEO120,000$5.39Sell$646,800.00
Oct. 1, 2014CEO10,000$4.27Sell$42,700.00
Sept. 2, 2014CEO10,000$4.78Sell$47,800.00
Aug. 1, 2014CEO10,000$4.37Sell$43,700.00
July 1, 2014CEO10,000$4.32Sell$43,200.00
June 19, 2014CEO7,000$4.00Sell$28,000.00
June 17, 2014CEO7,700$4.00Sell$30,800.00
June 17, 2014VP7,900$4.00Sell$31,600.00
June 13, 2014CEO11,800$4.02Sell$47,436.00
June 13, 2014VP11,700$4.02Sell$47,034.00
Oct. 1, 2012Director10,000$1.68Buy$16,800.00
First«1 of 1»Last
  • Insiders are both buying and selling Eyepoint Pharmaceuticals Inc stock.

  • The insider traders at Eyepoint Pharmaceuticals Inc are: Paul Ashton, Ew Healthcare Partners, L.P., Cormorant Asset Management, Lp, George Elston, Dario A Paggiarino, Ye Liu, David Scott Jones, Nancy Lurker, Leonard S. Ross, David R Guyer, Lori Freedman, Paul Hopper, Wendy F Dicicco, John B Landis, Jay S Duker, Michael Craig Pine, and Douglas Evan Godshall

  • The most active insider trader at Eyepoint Pharmaceuticals Inc is Paul Ashton with 8 trades.

  • Ye Liu has sold the most Eyepoint Pharmaceuticals Inc stock with a total value of $79,219,971.22.

  • Cormorant Asset Management, Lp has bought the most Eyepoint Pharmaceuticals Inc stock with a total value of $99,576,141.69.

  • The most recent insider trade for Eyepoint Pharmaceuticals Inc was on Aug. 20, 2024.

  • The single biggest insider buy for Eyepoint Pharmaceuticals Inc was from Cormorant Asset Management, Lp with a total value of $41,873,823.74 on Dec. 4, 2023.

  • The single biggest insider sell for Eyepoint Pharmaceuticals Inc was from Ye Liu with a total value of $37,159,225.00 on Jan. 11, 2024.